|
|
|
Insider
Information: |
Mario Ernest |
Relationship: |
Director |
City: |
Redwood City |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
13 |
|
Direct
Shares |
1,151,697 |
|
Indirect Shares
|
265,510 |
|
|
Direct
Value |
$8,420,214 |
|
|
Indirect Value
|
$116,216 |
|
|
Total
Shares |
1,417,207 |
|
|
Total
Value |
$8,536,430 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
3
|
0
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
2
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
-41.7%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Maxygen Inc |
MAXY |
Director |
2012-06-06 |
62,964 |
2003-08-05 |
0 |
Premium* |
|
Ardea Biosciences Inc |
RDEA |
Director |
2004-05-05 |
70,431 |
2004-05-05 |
85,554 |
Premium* |
|
Pharmaceutical Product Developme... |
PPDI |
Director |
2011-12-05 |
0 |
2011-12-05 |
0 |
Premium* |
|
Boston Scientific Corp |
BSX |
Director |
2015-11-16 |
86,032 |
2013-11-08 |
0 |
Premium* |
|
Alexza Pharmaceuticals Inc. |
ALXA |
Director |
2006-03-08 |
18,181 |
|
0 |
Premium* |
|
Celgene Corp |
CELG |
|
2019-11-20 |
0 |
2019-11-20 |
0 |
Premium* |
|
Vivus Inc |
VVUS |
Director |
2013-05-29 |
81,125 |
2012-04-25 |
0 |
Premium* |
|
Xenoport Inc |
XNPT |
Director |
2015-05-19 |
88,750 |
2012-08-09 |
0 |
Premium* |
|
Tonix Pharmaceuticals Holding Corp |
TNXP |
Director |
2018-02-09 |
0 |
2018-06-25 |
50,000 |
Premium* |
|
Chimerix Inc |
CMRX |
Director |
2018-05-18 |
12,905 |
2018-05-18 |
108,167 |
Premium* |
|
Kindred Biosciences, Inc. |
KIN |
Director |
2018-10-29 |
169,000 |
2013-12-12 |
0 |
Premium* |
|
Soleno Therapeutics Inc |
SLNO |
|
2024-05-21 |
186,566 |
2024-05-21 |
21,789 |
Premium* |
|
Eyenovia Inc |
EYEN |
Director |
2021-01-15 |
375,743 |
2018-07-24 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
373 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 9 of 15
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BSX |
Boston Scientific Corp |
Director |
|
2014-10-08 |
4 |
AS |
$12.06 |
$120,600 |
D/D |
(10,000) |
267,855 |
0 |
- |
|
BSX |
Boston Scientific Corp |
Director |
|
2014-11-03 |
4 |
AS |
$13.30 |
$132,998 |
D/D |
(10,000) |
271,032 |
0 |
- |
|
CMRX |
Chimerix Inc |
Director |
|
2014-11-05 |
4 |
B |
$29.00 |
$290,000 |
D/D |
10,000 |
106,053 |
2.39 |
- |
|
BSX |
Boston Scientific Corp |
Director |
|
2014-12-01 |
4 |
AS |
$12.96 |
$129,618 |
D/D |
(10,000) |
261,032 |
0 |
- |
|
SLNO |
Soleno Therapeutics Inc |
Director |
|
2015-08-12 |
4 |
B |
$1.64 |
$16,440 |
D/D |
10,000 |
1,327,520 |
3.92 |
- |
|
TNXP |
Tonix Pharmaceuticals Hol... |
Director |
|
2015-08-26 |
4 |
B |
$6.05 |
$60,500 |
D/D |
10,000 |
260,472 |
2.39 |
- |
|
CMRX |
Chimerix Inc |
Director |
|
2016-05-13 |
4 |
B |
$4.53 |
$45,328 |
D/D |
10,000 |
331,440 |
2.39 |
- |
|
TNXP |
Tonix Pharmaceuticals Hol... |
Director |
|
2017-12-18 |
4 |
S |
$3.57 |
$35,700 |
I/I |
(10,000) |
43,500 |
0 |
- |
|
TNXP |
Tonix Pharmaceuticals Hol... |
Director |
|
2018-02-09 |
4 |
GD |
$0.00 |
$0 |
D/D |
10,000 |
0 |
0 |
- |
|
TNXP |
Tonix Pharmaceuticals Hol... |
Director |
|
2018-02-09 |
4 |
GA |
$0.00 |
$0 |
I/I |
10,000 |
33,500 |
0 |
- |
|
CELG |
Celgene Corp |
|
|
2018-11-26 |
4 |
OE |
$59.06 |
$590,550 |
D/D |
10,000 |
54,413 |
0 |
- |
|
SLNO |
Soleno Therapeutics Inc |
Director |
|
2020-10-30 |
4 |
A |
$1.74 |
$17,499 |
D/D |
10,057 |
1,148,876 |
0 |
- |
|
SLNO |
Soleno Therapeutics Inc |
Director |
|
2020-07-31 |
4 |
A |
$1.72 |
$17,499 |
D/D |
10,174 |
10,174 |
0 |
- |
|
SLNO |
Soleno Therapeutics Inc |
Director |
|
2020-01-22 |
4 |
A |
$3.35 |
$35,001 |
D/D |
10,448 |
10,448 |
0 |
- |
|
PPDI |
Pharmaceutical Product De... |
Director |
|
2004-01-05 |
4 |
GD |
$0.00 |
$0 |
D/D |
12,000 |
314,226 |
|
- |
|
CELG |
Celgene Corp |
Director |
|
2017-02-27 |
4 |
S |
$121.24 |
$1,454,880 |
D/D |
(12,000) |
57,424 |
0 |
- |
|
CELG |
Celgene Corp |
|
|
2018-08-09 |
4 |
S |
$92.32 |
$1,107,888 |
D/D |
(12,000) |
44,413 |
0 |
- |
|
PPDI |
Pharmaceutical Product De... |
Director |
|
2006-12-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(12,500) |
589,594 |
0 |
- |
|
PPDI |
Pharmaceutical Product De... |
Director |
|
2006-12-18 |
4 |
D |
$0.00 |
$0 |
I/I |
(12,500) |
347,632 |
0 |
- |
|
PPDI |
Pharmaceutical Product De... |
Director |
|
2010-12-08 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
172,933 |
0 |
- |
|
PPDI |
Pharmaceutical Product De... |
Director |
|
2010-12-08 |
4 |
A |
$0.00 |
$0 |
I/I |
12,500 |
275,653 |
0 |
- |
|
KIN |
Kindred Biosciences, Inc. |
Director |
|
2014-02-05 |
4 |
OE |
$0.32 |
$4,000 |
D/D |
12,500 |
37,500 |
0 |
- |
|
PPDI |
Pharmaceutical Product De... |
Director |
|
2010-02-10 |
4 |
GD |
$0.00 |
$0 |
I/I |
12,936 |
225,191 |
0 |
- |
|
PPDI |
Pharmaceutical Product De... |
Director |
|
2010-02-10 |
4 |
GD |
$0.00 |
$0 |
D/D |
12,936 |
149,197 |
0 |
- |
|
BSX |
Boston Scientific Corp |
Director |
|
2014-10-31 |
4 |
A |
$0.00 |
$0 |
D/D |
13,177 |
281,032 |
0 |
- |
|
373 Records found
|
|
Page 9 of 15 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|